Net income
5Y CAGR +11.6%5Y CAGR +11.6%No quarters filed for this figure.
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Bar = where today’s multiple sits in NVS’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
No quarters filed for this figure.
No quarters filed for this figure.
No quarters filed for this figure.
FY25: operating cash flow $19.1B, capex −$1.5B
No quarters filed for this figure.
No quarters filed for this figure.
No quarters filed for this figure.
Novartis AG Sponsored ADR represents Novartis AG, a global healthcare company focused on developing, manufacturing, and commercializing prescription medicines and related healthcare products. Novartis serves major therapeutic areas including oncology, immunology, cardiovascular, neuroscience, and ophthalmology, with a portfolio built around innovative treatments for serious and chronic diseases. The company operates across research, development, production, and global distribution, supporting hospitals, physicians, and patients in markets worldwide. Novartis also includes medicines and platforms designed to improve access, formulation, and delivery of therapies, making it a significant participant in the pharmaceutical industry and the broader healthcare market. As a sponsored ADR, it provides U.S. investors with access to Novartis shares through an American depositary receipt structure.
Basel, Switzerland·75,267 employees·Drug Manufacturers - General·novartis.com·As of Oct 28, 2026
No earnings release, press release or insider trade outside a 10b5-1 plan in the last 120 days.
All filings and insider trades →11 of the 193 ETFs ChartRow carries live hold NVS. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| EWL | iShares MSCI Switzerland ETF | 12.3% |
| VIGI | Vanguard International Dividend Appreciation ETF | 3.5% |
| VGK | Vanguard FTSE Europe ETF | 1.8% |
| VYMI | Vanguard International High Dividend Yield ETF | 1.5% |
| EFA | iShares MSCI EAFE ETF | 1.3% |
| VEA | Vanguard FTSE Developed Markets ETF | 0.9% |
| VEU | Vanguard FTSE All-World ex-US ETF | 0.7% |
| VXUS | Vanguard Total International Stock ETF | 0.7% |
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +24.07% | +0.61% |
| JNJ | Johnson & Johnson | +7.92% | +3.81% |
| ABBV | AbbVie Inc. | +12.18% | +3.09% |
| MRK | Merck & Co. Inc. | +4.20% | +3.93% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +10.08% | +1.22% |
| TMO | Thermo Fisher Scientific Inc. | +7.84% | +1.12% |
| AMGN | Amgen Inc. | +18.69% | +3.71% |
| GILD | Gilead Sciences Inc. | +20.55% | +4.19% |